bourva

Samsung Biologics Net income

₩4.64T FY2024
207940 · Samsung Biologics Prices delayed ≥15 min Sample data

Net income over time

Net income by period

Period Net income
FY2024 ₩4.64T
FY2023 ₩8.49T
FY2022 ₩6.67T
FY2021 ₩2.71T
FY2020 ₩2T
Find your next idea
Screen stocks and ETFs across every market.